Section of Metabolic Tissue Engineering
«We support the industry in testing products using 3D living tissue that we have developed ourselves, without animal testing.»
The focus of our research is the construction of three-dimensional tissue cultures using human primary cells. We have been applying the methods of tissue engineering for over 10 years to various tissue types such as bone, cartilage and intervertebral discs, connective tissue and skin, the liver and the pancreas. These in vitro tissues and the use of various technologies provide the basis for many diverse objectives and applications.
Areas of expertise
Our developments are used in areas such as
- Cell culture technology: automated processes, consideration of biomechanical aspects and bioprinting
- Biomaterials and implants: development, characterisation, surface modification and in vitro studies
- Medicine: regenerative, cell-based therapies and clinical trials
- Drug development: Cultivation and use of organotypic models for substance evaluation
Our research laboratories provide a modern infrastructure and methodological expertise.
We offer our project partners a wide range of opportunities for cooperation. Customer-specific concerns are the principal focus of Bachelor's and Master's theses, directly funded collaborations, and CTI projects.
Competence centre "Tissue Engineering for Drug Development, TEDD"
The centre was founded in 2010 by the members of the section “Tissue Engineering” and has succeeded in combining knowledge, technologies and partners from research and industry.
Publications of the section
-
Sorushanova, Anna; Delgado, Luis M.; Wu, Zhuning; Shologu, Naledi; Kshirsagar, Aniket; Raghunath, Rufus; Mullen, Anne M.; Bayon, Yves; Pandit, Abhay; Raghunath, Michael; Zeugolis, Dimitrios I.,
2018.
The collagen suprafamily : from biosynthesis to advanced biomaterial development.
Advanced Materials.
Available from: https://doi.org/10.1002/adma.201801651
-
Blocki, Anna; Beyer, Sebastian; Jung, Friedrich; Raghunath, Michael,
2018.
Clinical Hemorheology and Microcirculation.
69(1-2), pp. 215-232.
Available from: https://doi.org/10.3233/CH-189132
-
Pugliese, Eugenia; Coentro, João Q.; Raghunath, Michael; Zeugolis, Dimitrios I.,
2018.
Advanced Drug Delivery Reviews.
129.
Available from: https://doi.org/10.1016/j.addr.2018.05.010
-
Goralczyk, Anna; van Vijven, Marc; Koch, Mathilde; Badowski, Cedric; Yassin, M. Shabeer; Toh, Sue-Anne; Shabbir, Asim; Franco-Obregón, Alfredo; Raghunath, Michael,
2017.
The FASEB Journal.
31(8).
Available from: https://doi.org/10.1096/fj.201601081RR
-
Rimann, Markus; Bono, Epifania; Laternser, Sandra; Nosswitz, Michael; Morel, Alexandre; Keller, Hansjörg; Leupin, Olivier; Wagner, Carsten; Graf-Hausner, Ursula; Raghunath, Michael,
2017.
3D bioprinted tissue models for substance testing.
In:
International Conference and Exhibition - Society for Laboratory Automation and Screening (SLAS 2017), Washington, USA, 4–8 February 2017.